Endotherapy for Barrett's esophagus: Which, how, when, and who?
Recent developments in endoscopic therapeutic options for Barrett's esophagus (BE) early neoplasia have resulted in a dramatic paradigm shift in its clinical management. With multiple endoscopic choices available, it is important to discern subtle differences between these approaches based on the available current data and known limitations of each modality. The goals of endoscopic therapy of Barrett's neoplasia are to preserve the esophagus while ablating or removing the entire BE segment. This article reviews the currently available BE endoscopic treatments with emphasis on appropriate selection of patients, indications and timing of use, and clinical management considerations.
Center for Endoscopic Research and Therapeutics, Section of Gastroenterology, Department of Medicine, The University of Chicago Medical Center, 5758 South Maryland Avenue, MC 9028, Chicago, IL 60637-1463, USA.
Jennifer
J
Chennat
Vani J A
VJ
Konda
Irving
I
Waxman
D001471:Barrett Esophagus / Q000601:surgery*; D017115:Catheter Ablation; D003452:Cryosurgery; D004210:Dissection / Q000379:methods; D004938:Esophageal Neoplasms / Q000601:surgery*; D004945:Esophagoscopy / Q000379:methods*; D006801:Humans; D009092:Mucous Membrane / Q000601:surgery; D010778:Photochemotherapy; D011230:Precancerous Conditions / Q000601:surgery*